Quick Links


2015 Quebec-France MS ALS Meeting

Montreal Neurological Institute Jeanne Timmins Amphitheatre, 3801 rue University, Montreal, QC, H3A 2B4, CA

The 3rd Biogen Idec-sponsored meeting of MS and ALS researchers in Quebec and Montpellier France will be held at the Neuro on October 15 and 16, 2015.   This meeting is co-organized by the Neuro and William Camu, Montpelier (France).

Everything in moderation: excessive nerve cell pruning leads to disease

Mechanism meant to maintain efficiency of brain network involved in neurodegenerative disease

Published: 8Oct2013

June is ALS Awareness Month

What is ALS?
Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease, is a neurodegenerative disease in which progressive muscle weakness leads to paralysis. ALS is a result of the death of motor neurons (nerve cells) in the brain and spinal cord that control voluntary muscle movement. Most people survive less than five years following diagnosis, but a small percentage of patients live for ten years or even longer. So far, there is no cure. About 3,000 Canadian adults have ALS and less than 1 in 10 patients have a family history of the disease. 

Published: 13Jun2013